QuartzBio Secures Growth Investment from Eir Partners to Accelerate Clinical Trial Intelligence

B New capital fuels product enhancements as leading biopharma adopt QuartzBio to eliminate operational inefficiencies and protect trial outcomes BALTIMORE, May 13, 2026 /PRNewswire/ — QuartzBio,…
posteditor
posteditor
Articles: 21727

Other News